Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

NCT00281957

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • Eden Hospital Medical Center Castro Valley, California, United States
  • Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States
View all 173 locations
View Trial Details
Completed

Tailored Intervention for Melanoma Patient's Families

NCT00816374

Conditions
Melanoma, Melanoma, Cutaneous Malignant, Neoplasms, +10 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

NCT01266967

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Ann Arbor, Michigan, United States
View all 24 locations
View Trial Details
Completed

Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor

NCT01037127

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

NCT01014351

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Oncology Hematology of SW Indiana Evansville, Indiana, United States
  • Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States
View Trial Details

Related conditions